• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CRO Frontage and Fanghui Pharma launch collaboration

CRO Frontage and Fanghui Pharma launch collaboration

February 23, 2012
CenterWatch Staff

An emerging Chinese pharmaceutical company just launched a new globalization strategy by tapping the pharmaceutical R&D, manufacturing, registration and marketing expertise of global CRO Frontage Laboratories.

Luohe Fanghui Pharmaceuticals of Henan Province, China, signed a $10 million agreement with Frontage after seeking assistance in growth strategies from a variety of sources.  “We selected Frontage based on its success in helping many Chinese pharmaceutical companies develop products for international markets,” said Fanghui Chairman Xiyuan Zhao.

“We are pleased to participate as a strategic resource in Fanghui’s enterprise globalization efforts,” said Song Li, founder and CEO of Frontage. “This agreement furthers our own plans to provide more infrastructure development, GMP and regulatory guidance, and facility construction consultation to Chinese pharmaceutical companies.”

Frontage will first serve as general strategic consultant for construction of new facilities.  This includes equipment selection and process validation to support Fanghui’s product pipeline, coordination of third-party engineering and architectural contractors and ensuring the facilities meet international regulatory standards. Frontage also will help establish a solid dosage manufacturing platform for generic and new products compliant with current good manufacturing practices.

The agreement also guides the process of establishing new quality systems that meet Chinese and international GXP guidelines, and the filing of generic and new drug applications simultaneously in the U.S. and China.  Finally, Frontage will help Fanghui conduct international market research to identify suitable and potentially profitable products for its pipeline.

Frontage Laboratories operates in the U.S. and China, running two phase I clinical units in China and one in Hackensack, N.J. It also operates a preclinical animal facility and bioanalytical and CMC facilities in Pennsylvania, and bioanalytical and CMC facilities in China.

Fanghui Pharmaceuticals was founded in 1969 in central China. Fanghui owns more than 100 products approved by the Chinese State Food and Drug Administration (SFDA).

 

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing